The neuroendocrine circuitry controlled by POMC, MSH, and AGRP

Handbook of Experimental Pharmacology

Volumn 209, Issue , 2012, Pages 47-50

  Biebermann, Heike ^a   Kühnen, Peter ^a   Kleinau, Gunnar ^a   Krude, Heiko ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AgRP; MC3R; MC4R; MSH; Mutations; POMC

Indexed keywords

AGOUTI RELATED PROTEIN; HYDROCORTISONE; INTERMEDIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MK 0493; N 1 [2 [1 (TERT BUTYL 4 (2,4 DIFLUOROPHENYL)PYRROLIDIN 3 YL) 5 CHLOROPHENYL]ETHYL]ACETAMIDE; PROOPIOMELANOCORTIN; SIBUTRAMINE; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ARTICLE; BODY WEIGHT; BRAIN FUNCTION; ENERGY EXPENDITURE; FOOD INTAKE; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LOW DRUG DOSE; MELANOCORTIN 3 RECEPTOR GENE; MELANOCORTIN 4 RECEPTOR GENE; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROOPIOMELANOCORTIN GENE; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; WEIGHT CONTROL; ANIMAL; EATING; ENERGY METABOLISM; GENETICS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MUTATION; PATHOPHYSIOLOGY; REVIEW;

AGOUTI-RELATED PROTEIN; ANIMALS; BODY WEIGHT; EATING; ENERGY METABOLISM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; MELANOCYTE-STIMULATING HORMONES; MUTATION; OBESITY; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION;

EID: 84856325848     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-24716-3_3     Document Type: Article

References (147)

1. Abbott CR, Rossi M, Kim M, AlAhmed SH, Taylor GM, Ghatei MA, Smith DM, Bloom SR2000) Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor. Brain Res 869:203-210 (Pubitemid 30345791)
2. Adan RA2006) Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system. Trends Pharmacol Sci 27:183-186
3. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123:493-505 (Pubitemid 41546678)
4. Barsh G1999) From Agouti to Pomc-100 years of fat blonde mice. Nat Med 5:984-985 (Pubitemid 29439560)
5. Barsh GS, Farooqi IS, O'Rahilly S2000) Genetics of body-weight regulation. Nature 404:644-651 (Pubitemid 30205069)
6. Barsh GS, Ollmann MM, Wilson BD, Miller KA, Gunn TM1999) Molecular pharmacology of Agouti protein in vitro and in vivo. Ann N Y Acad Sci 885:143-152
7. Barth N, Ziegler A, Himmelmann GW, Coners H, Wabitsch M, Hennighausen K, Mayer H, Remschmidt H, Schafer H, Hebebrand J1997) Significant weight gains in a clinical sample of obese children and adolescents between 1985 and 1995. Int J Obes Relat Metab Disord 21:122-126 (Pubitemid 27075597)
8. Belgardt BF, Okamura T, Bruning JC2009) Hormone and glucose signalling in POMC and AgRP neurons. J Physiol 587:5305-5314
9. Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z, Ghatei MA, Bloom SR2005) Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 19:1680-1682 (Pubitemid 41429528)
10. Biebermann H, Castaneda TR, van Landeghem F, von Deimling A, Escher F, Brabant G, Hebebrand J, Hinney A, Tschop MH, Gruters A, Krude H2006) A role for beta-melanocyte- stimulating hormone in human body-weight regulation. Cell Metab 3:141-146
11. Biebermann H, Krude H, Elsner A, Chubanov V, Gudermann T, Gruters A2003) Autosomaldominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52:2984-2988 (Pubitemid 37466869)
12. Breit A, Buch TR, Boekhoff I, Solinski HJ, Damm E, Gudermann T2011) Alternative G protein coupling and biased agonism: new insights into melanocortin-4 receptor signalling. Mol Cell Endocrinol 331:232-240
13. Broberger C, Hokfelt T2001) Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav 74:669-682 (Pubitemid 34081212)
14. Buch TR, Heling D, Damm E, Gudermann T, Breit A2009) Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J Biol Chem 284:26411-26420
15. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptordeficient mouse. Endocrinology 141:3518-3521 (Pubitemid 32269044)
16. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N, Vaisse C2009) Association of functionally significantMelanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet 18:1140-1147
17. Challis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GS, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly S2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortinPOMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:1997-2004 (Pubitemid 34919274)
18. Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, Balding D, Scott J, Kooner JS2008) Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 40:716-718 (Pubitemid 351748872)
19. Chan LF, Webb TR, Chung TT, Meimaridou E, Cooray SN, Guasti L, Chapple JP, Egertova M, Elphick MR, Cheetham ME, Metherell LA, Clark AJ2009) MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc Natl Acad Sci USA 106:6146-6151
20. ChenAS,Marsh DJ, TrumbauerME, Frazier EG,GuanXM, Yu H, RosenblumCI, VongsA, FengY, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal- Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102
21. Chen M, Aprahamian CJ, Celik A, Georgeson KE, Garvey WT, Harmon CM, Yang Y2006) Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry 45:1128-1137 (Pubitemid 43167180)
22. Chen M, Cai M, Aprahamian CJ, Georgeson KE, Hruby V, Harmon CM, Yang Y2007) Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4, D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling. J Biol Chem 282:21712-21719 (Pubitemid 47195764)
23. Clement K, Dubern B, Mencarelli M, Czernichow P, Ito S, Wakamatsu K, Barsh GS, Vaisse C, Leger J2008) Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab 93:4955-4962
24. Cone RD1999) The ups and downs of leptin action. Endocrinology 140:4921-4922
25. Cone RD2000) The melanocortin receptors. Humana, NJ
26. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295 (Pubitemid 26033933)
27. Creemers JW, Lee YS, Oliver RL, Bahceci M, Tuzcu A, Gokalp D, Keogh J, Herber S, White A, O'Rahilly S, Farooqi IS2008) Mutations in the amino-terminal region of proopiomelanocortinPOMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. J Clin Endocrinol Metab 93:4494-4499 (Pubitemid 352789552)
28. Cuenot L1909) Recent views of L. Cuenot on the origin of species by mutation. Science 30:768-769
29. Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T, Schafer H, Hebebrand J2004) Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 41:795-800 (Pubitemid 39389299)
30. Dubern B, Lubrano-Berthelier C, Mencarelli M, Ersoy B, FrelutML, Bougle D, Costes B, Simon C, Tounian P, Vaisse C, Clement K2008)Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the alpha-melanocyte stimulating hormone domain. Pediatr Res 63:211-216
31. Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS1994) Neomorphic agouti mutations in obese yellow mice. Nat Genet 8:59-65 (Pubitemid 24274061)
32. Elsner A, Tarnow P, Schaefer M, Ambrugger P, Krude H, Gruters A, Biebermann H2006) MC4R oligomerizes independently of extracellular cysteine residues. Peptides 27:372-379 (Pubitemid 43162908)
33. Fan ZC, Sartin JL, Tao YX2008) Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J Endocrinol 196:139-148 (Pubitemid 351234579)
34. Farooqi IS, Drop S, Clements A, Keogh JM, Biernacka J, Lowenbein S, Challis BG, O'Rahilly S2006) Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 55:2549-2553 (Pubitemid 44871155)
35. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279 (Pubitemid 30483131)
36. Farooqi IS, Yeo GS, O'Rahilly S2003) Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 349:606-609, author reply 606-9 (Pubitemid 36951374)
37. Farooqi S2007) Insights from the genetics of severe childhood obesity. Horm Res 68(Suppl 5):5-7
38. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J2001) The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 86:1144-1148 (Pubitemid 32322995)
39. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, Yanovski JA2005) Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 54:2663-2667 (Pubitemid 41233588)
40. Flier JS2006) AgRP in energy balance: will the real AgRP please stand up? Cell Metab 3:83-85
41. Fong TM, Strack AM2008) Melanocortin-4 receptor as a new target for drug development. Handbook of obesity 3 rd edn: 389-394
42. Fox DL, Vella KR, Good DJ2007) Energy balance pathways converging on the Nhlh2 transcription factor. Front Biosci 12:3983-3993
43. Fu LY, van den Pol AN2008) Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons. J Neurosci 28:5433-5449
44. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T1993a) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-15179 (Pubitemid 23206671)
45. Gantz I, Tashiro T, Barcroft C, Konda Y, Shimoto Y, Miwa H, Glover T, Munzert G, Yamada T1993b) Localization of the genes encoding the melanocortin-2adrenocorticotropic hormone) and melanocortin-3 receptors to chromosomes 18p11.2 and 20q13.2-q13.3 by fluorescence in situ hybridization. Genomics 18:166-167 (Pubitemid 23305029)
46. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP1987) Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 16:235-251 (Pubitemid 17067798)
47. Garza JC, Kim CS, Liu J, Zhang W, Lu XY2008) Adeno-associated virus-mediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes highfat diet-induced hyperphagia and obesity. J Endocrinol 197:471-482 (Pubitemid 351803952)
48. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J2004) Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 74:572-581 (Pubitemid 38325928)
49. Gotoda T, Scott J, Aitman TJ1997) Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin. Diabetologia 40:976-979 (Pubitemid 27316581)
50. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL1997) Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 17:273-274
51. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS2009) Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360:44-52
52. Grieco P, Balse-Srinivasan P, Han G, Weinberg D, MacNeil T, Van der Ploeg LH, Hruby VJ2003) Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5. J Pept Res 62:199-206 (Pubitemid 37338830)
53. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, Barsh GS, Horvath TL, Bruning JC2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8:1289-1291 (Pubitemid 41630413)
54. Guo L, Ye Z, Liu J, He S, Bakshi RK, Sebhat IK, Dobbelaar PH, Hong Q, Jian T, Dellureficio JP, Tsou NN, Ball RG, Weinberg DH, MacNeil T, Tang R, Tamvakopoulos C, Peng Q, Chen HY, Chen AS, Martin WJ, MacIntyre DE, Strack AM, Fong TM, Wyvratt MJ, Nargund RP2010) Discovery of potent, selective, and orally bioavailable 3 H-spiro[isobenzofuran-1,40-piperidine] based melanocortin subtype-4 receptor agonists. Bioorg Med Chem Lett 20:4895-4900
55. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, Vaillant E, Lorentz N, Basdevant A, Clement K, Guy-Grand B, Froguel P1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20:304-308 (Pubitemid 28507680)
56. Hani EH, Dupont S, Durand E, Dina C, Gallina S, Gantz I, Froguel P2001) Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 86:2895-2898 (Pubitemid 32545758)
57. Haqq AM, Rene P, Kishi T, Khong K, Lee CE, Liu H, Friedman JM, Elmquist JK, Cone RD2003) Characterization of a novel binding partner of the melanocortin-4 receptor: attractin-like protein. Biochem J 376:595-605 (Pubitemid 38058059)
58. Harrold JA, Williams G2006) Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides 27:365-371 (Pubitemid 43162907)
59. Haskell-Luevano C, Monck EK2001) Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99:1-7 (Pubitemid 32232121)
60. He S, Ye Z, Dobbelaar PH, Sebhat IK, Guo L, Liu J, Jian T, Lai Y, Franklin CL, Bakshi RK, Dellureficio JP, Hong Q, Tsou NN, Ball RG, Cashen DE, Martin WJ, Weinberg DH, Macneil T, Tang R, Tamvakopoulos C, Peng Q, Miller RR, Stearns RA, Chen HY, Chen AS, Strack AM, Fong TM, Macintyre DE, Wyvratt MJ Jr, Nargund RP2010a) Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. Bioorg Med Chem Lett 20:2106-2110
61. He S, Ye Z, Dobbelaar PH, Sebhat IK, Guo L, Liu J, Jian T, Lai Y, Franklin CL, Bakshi RK, Dellureficio JP, Hong Q, Weinberg DH, Macneil T, Tang R, Strack AM, Tamvakopoulos C, Peng Q, Miller RR, Stearns RA, Chen HY, Chen AS, Fong TM, Wyvratt MJ Jr, Nargund RP2010b) Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. Bioorg Med Chem Lett 20:4399-4405
62. Heid IM, Vollmert C, Hinney A, Doring A, Geller F, Lowel H, Wichmann HE, Illig T, Hebebrand J, Kronenberg F2005) Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 42:e21
63. Hinney A, Becker I, Heibult O, Nottebom K, Schmidt A, Ziegler A, Mayer H, Siegfried W, Blum WF, Remschmidt H, Hebebrand J1998) Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J Clin Endocrinol Metab 83:3737-3741 (Pubitemid 28500918)
64. Hinney A, Bettecken T, Tarnow P, Brumm H, Reichwald K, Lichtner P, Scherag A, Nguyen TT, Schlumberger P, Rief W, Vollmert C, Illig T, Wichmann HE, Schafer H, Platzer M, Biebermann H, Meitinger T, Hebebrand J2006) Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab 91:1761-1769
65. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schafer H, Gudermann T, Hebebrand J2003) Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88:4258-4267 (Pubitemid 37153729)
66. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, Gerber G, Sina M, Gorg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J1999) Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 84:1483-1486 (Pubitemid 30644420)
67. Ho G, MacKenzie RG1999) Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. J Biol Chem 274:35816-35822 (Pubitemid 129512886)
68. Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, Al-Obeidi FA, Hadley ME, Cone RD1995) Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7, Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38:3454-3461
69. Hruby VJ, Wilkes BC, Hadley ME, Al-Obeidi F, Sawyer TK, Staples DJ, de Vaux AE, Dym O, Castrucci AM, Hintz MF et al1987) alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem 30:2126-2130 (Pubitemid 18046075)
70. Hughes DA, Hinney A, Brumm H, Wermter AK, Biebermann H, Hebebrand J, Stoneking M2009) Increased constraints on MC4R during primate and human evolution. Hum Genet 124:633-647
71. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141 (Pubitemid 27180337)
72. Irani BG, Xiang Z, Moore MC, Mandel RJ, Haskell-Luevano C2005) Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse. Biochem Biophys Res Commun 326:638-644 (Pubitemid 39642772)
73. Kask A, Rago L, Wikberg JE, Schioth HB2000) Differential effects of melanocortin peptides on ingestive behaviour in rats: evidence against the involvement of MC(3) receptor in the regulation of food intake. Neurosci Lett 283:1-4 (Pubitemid 30145482)
74. Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T, Hino M, Ishihara T, Ikekubo K, Kurahachi H, Nakao K2002) A Novel homozygous missense mutation of melanocortin-4 receptorMC4R) in a Japanese woman with severe obesity. Diabetes 51:243-246 (Pubitemid 34518005)
75. Krishna R, Gumbiner B, Stevens C, Musser B, Mallick M, Suryawanshi S, Maganti L, Zhu H, Han TH, Scherer L, Simpson B, Cosgrove D, Gottesdiener K, Amatruda J, Rolls BJ, Blundell J, Bray GA, Fujioka K, Heymsfield SB, Wagner JA, Herman GA2009) Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther 86:659-666
76. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157 (Pubitemid 28248796)
77. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, Gruters A2003) Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88:4633-4640 (Pubitemid 37357504)
78. Krude H, Gruters A2000) Implications of proopiomelanocortinPOMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab 11:15-22 (Pubitemid 30395455)
79. Kublaoui BM, Holder JL Jr, Gemelli T, Zinn AR2006) Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol Endocrinol 20:2483-2492 (Pubitemid 44496416)
80. Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, Blackwood A, Hung CC, Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS2006) A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 3:135-140
81. Lee YS, Poh LK, Kek BL, Loke KY2007) The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 56:2622-2630 (Pubitemid 47523271)
82. Lee YS, Poh LK, Loke KY2002) A novel melanocortin 3 receptor geneMC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87:1423-1426 (Pubitemid 36121119)
83. Li WD, Joo EJ, Furlong EB, Galvin M, Abel K, Bell CJ, Price RA2000) Melanocortin 3 receptorMC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 24:206-210 (Pubitemid 30107570)
84. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, Berndt SI, Jacobs KB, Chanock SJ, Hayes RB, Bergmann S, Bennett AJ, Bingham SA, Bochud M, Brown M, Cauchi S, Connell JM, Cooper C, Smith GD, Day I, DinaC, De S, Dermitzakis ET, Doney AS, Elliott KS, Elliott P, Evans DM, Sadaf Farooqi I, Froguel P, Ghori J, Groves CJ, Gwilliam R, Hadley D, Hall AS, Hattersley AT, Hebebrand J, Heid IM, Lamina C, Gieger C, Illig T, Meitinger T, Wichmann HE, Herrera B, Hinney A, Hunt SE, Jarvelin MR, Johnson T, Jolley JD, Karpe F, Keniry A, Khaw KT, Luben RN, Mangino M, Marchini J, McArdle WL, McGinnis R, Meyre D, Munroe PB, Morris AD, Ness AR, Neville MJ, Nica AC, Ong KK, O'Rahilly S, Owen KR, Palmer CN, Papadakis K, Potter S, Pouta A, Qi L, Randall JC, Rayner NW, Ring SM, Sandhu MS, Scherag A, Sims MA, Song K, Soranzo N, Speliotes EK, Syddall HE, Teichmann SA, Timpson NJ, Tobias JH, Uda M, Vogel CI, Wallace C, Waterworth DM, Weedon MN, Willer CJ, Wraight YX, Zeggini E, H schhorn JN, Strachan DP, Ouwehand WH, Caulfield MJ et al2008) Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40:768-775 (Pubitemid 351748863)
85. Lu XY, Barsh GS, Akil H, Watson SJ2003) Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamopituitary- adrenal responses. J Neurosci 23:7863-7872 (Pubitemid 37052354)
86. Lubrano-Berthelier C, Cavazos M, Le Stunff C, Haas K, Shapiro A, Zhang S, Bougneres P, Vaisse C2003) The human MC4R promoter: characterization and role in obesity. Diabetes 52:2996-3000 (Pubitemid 37466871)
87. Lubrano-Berthelier C, Le Stunff C, Bougneres P, Vaisse C2004) A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J Clin Endocrinol Metab 89:2028-2032 (Pubitemid 38619828)
88. Luquet S, Perez FA, Hnasko TS, Palmiter RD2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310:683-685 (Pubitemid 41528162)
89. Ma L, Tataranni PA, Bogardus C, Baier LJ2004) Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians. Diabetes 53:2696-2699 (Pubitemid 39299281)
90. Maes HH, Neale MC, Eaves LJ1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27:325-351 (Pubitemid 27415169)
91. Mandrika I, Petrovska R, Wikberg J2005) Melanocortin receptors form constitutive homo- and heterodimers. Biochem Biophys Res Commun 326:349-354 (Pubitemid 39593554)
92. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21:119-122 (Pubitemid 29036297)
93. Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, Blackwood A, O'Rahilly S, Roelfsema F, Camacho-Hubner C, Pijl H, Farooqi IS2011) Obesity due to melanocortin 4 receptorMC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 96:E181-E188
94. Mencarelli M, Dubern B, Alili R, Maestrini S, Benajiba L, Tagliaferri M, Galan P, Rinaldi M, Simon C, Tounian P, Hercberg S, Liuzzi A, Di Blasio AM, Clement K2011) Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum Mol Genet 20:392-399
95. Mencarelli M, Walker GE, Maestrini S, Alberti L, Verti B, Brunani A, Petroni ML, Tagliaferri M, Liuzzi A, Di Blasio AM2008) Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 16:581-586 (Pubitemid 351594124)
96. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME, Clark AJ2005) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37:166-170
97. Millington GW, Tung YC, Hewson AK, O'Rahilly S, Dickson SL2001) Differential effects of alpha-, beta- and gamma(2)-melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat. Neuroscience 108:437-445 (Pubitemid 34037890)
98. Miltenberger RJ, Mynatt RL, Bruce BD, Wilkison WO, Woychik RP, Michaud EJ1999) An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice. Proc Natl Acad Sci USA 96:8579-8584 (Pubitemid 29354834)
99. Mountjoy KG, Kong PL, Taylor JA, Willard DH, Wilkison WO2001) Melanocortin receptormediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genomics 5:11-19 (Pubitemid 33675198)
100. Mountjoy KG, Wu CS, Cornish J, Callon KE2003) alpha-MSH and desacetyl-alpha-MSH signaling through melanocortin receptors. Ann N Y Acad Sci 994:58-65 (Pubitemid 36793850)
101. Munzberg H, Huo L, Nillni EA, Hollenberg AN, Bjorbaek C2003) Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144:2121-2131 (Pubitemid 36543352)
102. Newman EA, Chai BX, Zhang W, Li JY, Ammori JB, Mulholland MW2006) Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons. J Surg Res 132:201-207
103. Nickolls SA, Maki RA2006) Dimerization of the melanocortin 4 receptor: a study using bioluminescence resonance energy transfer. Peptides 27:380-387 (Pubitemid 43162909)
104. Nijenhuis WA, Oosterom J, Adan RA2001) AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164-171 (Pubitemid 32156049)
105. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138 (Pubitemid 27446294)
106. Oosterom J, GarnerKM, den DekkerWK, NijenhuisWA, GispenWH, Burbach JP, Barsh GS, Adan RA2001) Common requirements for melanocortin-4 receptor selectivity of structurally unrelatedmelanocortin agonist and endogenous antagonist, Agouti protein. J Biol Chem276:931-936 (Pubitemid 32096511)
107. Poggioli R, Vergoni AV, Bertolini A1986) ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides 7:843-848 (Pubitemid 17182352)
108. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van der Ploeg LH, Marsh DJ2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22:5027-5035 (Pubitemid 34700694)
109. Rached M, Buronfosse A, Begeot M, Penhoat A2004) Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta 1689:229-234 (Pubitemid 38981600)
110. Rediger A, Tarnow P, Bickenbach A, Schaefer M, Krude H, Gruters A, Biebermann H2009) Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation. Obes Facts 2:80-86
111. Roubert P, Dubern B, Plas P, Lubrano-Berthelier C, Alihi R, Auger F, Deoliveira DB, Dong JZ, Basdevant A, Thurieau C, Clement K2010) Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response. J Endocrinol 207:177-183
112. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, Mustajoki P, Heikinheimo M, Kontula K2003) Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 27:70-74 (Pubitemid 36152782)
113. Schioth HB, Petersson S, Muceniece R, Szardenings M, Wikberg JE1997) Deletions of the Nterminal regions of the human melanocortin receptors. FEBS Lett 410:223-228 (Pubitemid 27304069)
114. Sebhat IK, Martin WJ, Ye Z, Barakat K, Mosley RT, Johnston DB, Bakshi R, Palucki B, Weinberg DH, MacNeil T, Kalyani RN, Tang R, Stearns RA, Miller RR, Tamvakopoulos C, Strack AM, McGowan E, Cashen DE, Drisko JE, Hom GJ, Howard AD, MacIntyre DE, van der Ploeg LH, Patchett AA, Nargund RP2002) Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1- (4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1 H-1,2,4-triazol- 1- ylmethyl)piperidin-1- yl]-2-oxoethylamine1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 45:4589-4593
115. Slominski A, Plonka PM, Pisarchik A, Smart JL, Tolle V, Wortsman J, Low MJ2005) Preservation of eumelanin hair pigmentation in proopiomelanocortin- deficient mice on a nonagoutia/a) genetic background. Endocrinology 146:1245-1253 (Pubitemid 40289312)
116. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD2000) A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 97:12339-12344
117. Stutzmann F, Tan K, Vatin V, Dina C, Jouret B, Tichet J, Balkau B, Potoczna N, Horber F, O'Rahilly S, Farooqi IS, Froguel P, Meyre D2008) Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57:2511-2518
118. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O, Tounian P, Levy-Marchal C, Buzzetti R, Pinelli L, Balkau B, Horber F, Bougneres P, Froguel P, Meyre D2007) Nonsynonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet 16:1837-1844 (Pubitemid 47244532)
119. Sutton GM, Duos B, Patterson LM, Berthoud HR2005) Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 146:3739-3747 (Pubitemid 41175741)
120. Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, Babin MJ, Meyer EA, Butler AA2006) Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6 J mice lacking melanocortin-3 or-4 receptors. Endocrinology 147:2183-2196
121. Tao YX2005) Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239:1-14
122. Tao YX2007) Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim Biophys Acta 1772:1167-1174
123. Tao YX2010a) The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev 31:506-543
124. Tao YX2010b) Mutations in the melanocortin-3 receptorMC3R) gene: Impact on human obesity or adiposity. Curr Opin Investig Drugs 11:1092-1096
125. Tao YX, Segaloff DL2004) Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 89:3936-3942 (Pubitemid 39071496)
126. Tarnow P, Rediger A, Brumm H, Ambrugger P, Rettenbacher E, Widhalm K, Hinney A, Kleinau G, Schaefer M, Hebebrand J, Krause G, Gruters A, Biebermann H(2008) A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability of the MC4R. Obes Facts 1:155-162
127. Tarnow P, Schoneberg T, Krude H, Gruters A, Biebermann H2003) Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. J Biol Chem 278:48666-48673 (Pubitemid 41079506)
128. Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M, Loo C, Garcia C, Sloane DL, Rosenthal A, Lin JC2008) TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology 149:1038-1048 (Pubitemid 351397944)
129. Vaisse C, Clement K, Guy-Grand B, Froguel P1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20:113-114 (Pubitemid 28455439)
130. Valli-Jaakola K, Palvimo JJ, Lipsanen-Nyman M, Salomaa V, Peltonen L, Kontula K, Schalin- Jantti C2006) A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Horm Res 66:61-69 (Pubitemid 44114429)
131. Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong SS, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar BD, Nelson RJ, MacIntyre DE2002) A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99:11381-11386 (Pubitemid 34920934)
132. Vergoni AV, Poggioli R, Bertolini A1986) Corticotropin inhibits food intake in rats. Neuropeptides 7:153-158 (Pubitemid 16105025)
133. Voisey J, van Daal A2002) Agouti: from mouse to man, from skin to fat. Pigment Cell Res 15:10-18 (Pubitemid 34535969)
134. Wang C, Godar RJ, Billington CJ, Kotz CM2010) Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet. Am J Physiol Regul Integr Comp Physiol 298:R1320-R1332
135. Wolff GL, Roberts DW, Mountjoy KG1999) Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics 1:151-163 (Pubitemid 129622462)
136. Wong J, Love DR, Kyle C, Daniels A, White M, Stewart AW, Schnell AH, Elston RC, Holdaway IM, Mountjoy KG2002) Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabetes Res Clin Pract 58:61-71 (Pubitemid 34823626)
137. Wortley KE, Anderson KD, Yasenchak J, Murphy A, Valenzuela D, Diano S, Yancopoulos GD, Wiegand SJ, SleemanMW(2005) Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab 2:421-427
138. Xiang Z, Litherland SA, Sorensen NB, Proneth B, Wood MS, Shaw AM, Millard WJ, Haskell- Luevano C2006) Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin- derived agonists and the agoutirelated proteinAGRP) antagonist. Biochemistry 45:7277-7288 (Pubitemid 43877414)
139. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736-742 (Pubitemid 36792889)
140. Yang Y2011) Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol 660:125-130
141. Yang Y, Chen M, Lai Y, Gantz I, Yagmurlu A, Georgeson KE, Harmon CM2003) Molecular determination of agouti-related protein binding to human melanocortin-4 receptor. Mol Pharmacol 64:94-103 (Pubitemid 36759822)
142. Yang YK, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR, Mosley R, Van Der Ploeg LH, Gantz I2000) Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 39:14900-14911
143. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U1999) Obesity in the mouse model of proopiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070 (Pubitemid 29439581)
144. Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL1994) Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J 8:479-488
145. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112 (Pubitemid 28455438)
146. Zegers D, Beckers S, de Freitas F, Peeters AV, Mertens IL, Verhulst SL, Rooman RP, Timmermans JP, Desager KN, Massa G, Van Gaal LF, Van Hul W2011) Identification of three novel genetic variants in the melanocortin-3 receptor of obese children. ObesitySilver Spring) 19:152-159
147. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 (Pubitemid 24365442)